RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
申请人:Beijing Tide Pharmaceutical Co., Ltd.
公开号:EP3770148A1
公开(公告)日:2021-01-27
The present invention discloses a receptor inhibitor of formula (I), a pharmaceutical composition comprising the same and the use thereof.
本发明公开了一种式(I)的受体抑制剂、由其组成的药物组合物及其用途。
[EN] RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF<br/>[FR] INHIBITEUR DE RÉCEPTEUR, COMPOSITION PHARMACEUTIQUE LE COMPRENANT ET SON UTILISATION<br/>[ZH] 受体抑制剂、包含其的药物组合物及其用途
申请人:BEIJING TIDE PHARMACEUTICAL CO LTD
公开号:WO2019179515A1
公开(公告)日:2019-09-26
式(I)的受体抑制剂、包含其的药物组合物及其用途。
Efficient Synthesis of Structurally Diverse Diazabicycloalkanes: Scaffolds for Modular Dipeptide Mimetics with Tunable Backbone Conformations
作者:Wolfgang Maison、Daniel C. Grohs、Alexander H. G. P. Prenzel
DOI:10.1002/ejoc.200300700
日期:2004.4
be easily converted into a number of dipeptide mimetics with defined and variable stereochemistry and a number of different amino acid side chains. The backbone dihedral angles within these dipeptide mimetics can be tuned by varying the stereochemistry and the ring sizes of the diazabicycloalkane scaffold. The syntheses of conformationallyconstraineddipeptide analogues in four to five steps are presented
A short stereoselective synthesis of disubstituted cyclic amino acids
作者:Wolfgang Maison、Gunadi Adiwidjaja
DOI:10.1016/s0040-4039(02)01267-4
日期:2002.8
A new synthetic route to enantiomericallypure disubstituted derivatives of cyclic aminoacids is reported. Key step of this synthesis is an oxidative cleavage of azabicycloalkene precursors that are synthesized in enantiomericallypure form via aza-Diels–Alder reaction. A range of different disubstituted pipecolic acid derivatives has been synthesized and their structure has been evaluated by X-ray